What Does a Rectal Suppository Do?
A rectal suppository delivers medication directly into the rectum, where it either acts locally on rectal tissue (e.g., treating inflammation in ulcerative proctitis or stimulating bowel movements in constipation) or is absorbed into the bloodstream for systemic effects, bypassing some of the liver's first-pass metabolism. 1, 2, 3
Primary Functions and Mechanisms
Local Action in the Rectum
For constipation relief, bisacodyl suppositories stimulate colonic peristalsis and secretion after being converted to their active metabolite in the colon, producing a bowel movement within 30–60 minutes. 1
Glycerin suppositories work through mild rectal irritation and mechanical lubrication, also achieving bowel evacuation within 30–60 minutes. 1
For ulcerative proctitis, 5-ASA (mesalazine) suppositories achieve much higher mucosal drug concentrations than oral therapy, working faster and more effectively for disease confined to the rectum. 4
Suppositories are specifically designed to remain in the rectum—scintigraphic studies confirm that suppository formulations stay confined to the rectal area, making them ideal for proctitis but inappropriate for more proximal disease. 5
Systemic Absorption
After insertion, the suppository base (typically lipophilic fats) melts at body temperature, releasing the active drug for absorption through the rectal mucosa. 6
The rectum offers a pharmacokinetic advantage: the lower and middle rectal veins drain directly into the systemic circulation, partially bypassing hepatic first-pass metabolism. 3, 7
This route can achieve higher bioavailability than oral administration for drugs with extensive first-pass metabolism (e.g., lidocaine, propranolol, ergotamine). 3, 7
Absorption from aqueous or alcoholic solutions occurs very rapidly, which has proven valuable for acute situations like suppressing convulsive attacks with diazepam. 3
Clinical Indications and Timing
When Suppositories Are First-Line Therapy
Digital rectal examination reveals a full rectum or fecal impaction: suppositories deliver medication directly to the site of obstruction. 1, 8
Mild to moderate ulcerative proctitis: 1 g 5-ASA suppositories are the recommended first-line treatment, superior to oral 5-ASA monotherapy. 4, 9
Patients who cannot swallow or have nausea/vomiting: the rectal route provides an alternative when oral administration is not feasible. 2, 3
Onset of Action
Bisacodyl and glycerin suppositories: 30–60 minutes for bowel movement. 1
This is dramatically faster than oral bisacodyl tablets, which require 6–12 hours because the drug must transit the entire gastrointestinal tract. 1
Critical Safety Considerations and Contraindications
Absolute Contraindications
Suppositories must never be used in patients with: 8, 10
- Paralytic ileus or mechanical intestinal obstruction (they cannot reach the blockage site and may worsen the condition)
- Severe neutropenia or thrombocytopenia (heightened infection and bleeding risk)
- Recent colorectal or gynecologic surgery (threat to anastomoses)
- Recent anal or rectal trauma
- Severe colitis, toxic megacolon, or intra-abdominal infection
- Recent pelvic radiotherapy (tissue fragility)
- Undiagnosed abdominal pain
Common Pitfalls to Avoid
Mistaking overflow diarrhea from fecal impaction for simple constipation can lead to missing a complete obstruction—always perform digital rectal examination and consider imaging if there is abdominal distention, vomiting, or absolute constipation. 10
Inadequate retention is the most common cause of treatment failure—if the suppository is expelled immediately after insertion, the therapeutic effect is delayed or abolished. 1
Patients with active rectal disease may experience discomfort preventing retention; in these cases, consider alternative formulations such as enemas or oral agents. 1
Factors Influencing Effectiveness
Suppository base composition critically affects drug release—the nature of the vehicle, use of surfactants, and particle size of the active ingredient all influence absorption rates. 3
Patient positioning and technique matter—proper insertion ensures the suppository is placed above the internal anal sphincter where it can be retained. 6
Disease extent determines appropriateness—suppositories are ideal for proctitis but ineffective for left-sided colitis, which requires enemas to reach the splenic flexure. 4, 9
Maintenance Therapy Considerations
For ulcerative proctitis, many patients respond promptly to 5-ASA suppositories and can use them on-demand when symptoms flare, which is safe given the low colorectal cancer risk in isolated proctitis. 4
For patients requiring regular preventive treatment, 5-ASA suppositories are the most effective maintenance therapy, though adherence must be weighed against patient preference—some may choose oral therapy for long-term use. 4
No dose response has been shown for 5-ASA suppositories at total daily doses greater than 1 g for proctitis. 9